Molecular imaging of neurodegeneration by a novel cross-disease biomarker

Experimental Neurology

Volumn 219, Issue 1, 2009, Pages 274-283

  Shirvan, Anat ^a   Reshef, Ayelet ^a   Yogev Falach, Merav ^a   Ziv, Ilan ^a  

^a Aposense Ltd   (Israel)

Author keywords

Alzheimer's diseases; Amyotrophic lateral sclerosis; Apoptosis; ApoSense; Molecular imaging

Indexed keywords

AMIDE; AMYLOID; BIOLOGICAL MARKER; CONGO RED; N (2 MERCAPTOETHYL)DANSYLAMIDE; N BUTYLDANSYLAMIDE; NST 727; NST 729; NST 739; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE SEVERITY; DRUG STRUCTURE; EARLY DIAGNOSIS; FEMALE; IMAGING; ISOTOPE LABELING; MALE; MEDULLA OBLONGATA; MOLECULAR IMAGING; MOLECULAR WEIGHT; MOTONEURON NUCLEUS; MOUSE; MOUSE MUTANT; NERVE CELL DEGENERATION; NERVE DEGENERATION; NERVE FIBER; NEURITE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PONS; PRIORITY JOURNAL; SENILE PLAQUE; SPINAL CORD; STAINING; SYMPTOM; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM; DANSYL COMPOUNDS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR PROBES; MOLECULAR STRUCTURE; MOTOR NEURONS; NERVE DEGENERATION; PREDICTIVE VALUE OF TESTS; SENILE PLAQUES; SENSITIVITY AND SPECIFICITY;

EID: 68549104029     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.05.032     Document Type: Article

References (55)

1. Aloya R., Shirvan A., Grimberg H., Reshef A., Levin G., Kidron D., Cohen A., and Ziv I. Molecular imaging of cell death in vivo by a novel small molecule probe. Apoptosis 11 (2006) 2089-2101
2. Bacskai B.J., Hickey G.A., Skoch J., Kajdasz S.T., Wang Y., Huang G.F., Mathis C.A., Klunk W.E., and Hyman B.T. Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12462-12467
3. Braskie M.N., Klunder A.D., Hayashi K.M., Protas H., Kepe V., Miller K.J., Huang S.C., Barrio J.R., Ercoli L.M., Siddarth P., Satyamurthy N., Liu J., Toga A.W., Bookheimer S.Y., Small G.W., and Thompson P.M. Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease. Neurobiol. Aging (2008) [Electronic publication ahead of print]
4. Camins A., Pallas M., and Silvestre J.S. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Find. Exp. Clin. Pharmacol. 30 (2008) 43-65
5. Cohen A., Shirvan A., Levin G., Grimberg H., Reshef A., and Ziv I. From the Gla domain to a novel small-molecule detector of apoptosis. Cell Res. 19 5 (2009) 625-637
6. Cohen A., Ziv I., Aloya T., Levin G., Kidron D., Grimberg H., Reshef A., and Shirvan A. Monitoring of chemotherapy-induced cell death in melanoma tumors by N,N′-didansyl-l-cystine. Technol. Cancer Res. Treat. 6 (2007) 221-234
7. Cohen A.S. Amyloidosis. N. Engl. J. Med. 277 (1967) 522-530 contd.
8. Damianovich M., Ziv I., Heyman S.N., Rosen S., Shina A., Kidron D., Aloya T., Grimberg H., Levin G., Reshef A., Bentolila A., Cohen A., and Shirvan A. ApoSense: a novel technology for functional molecular imaging of cell death in models of acute renal tubular necrosis. Eur. J. Nucl. Med. Mol. Imaging 33 (2006) 281-291
9. Dickson T.C., and Vickers J.C. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience 105 (2001) 99-107
10. Dodel R., Csoti I., Ebersbach G., Fuchs G., Hahne M., Kuhn W., Oechsner M., Jost W., Reichmann H., and Schulz J.B. Lewy body dementia and Parkinson's disease with dementia. J. Neurol. 255 Suppl. 5 (2008) 39-47
11. Fiala J.C. Mechanisms of amyloid plaque pathogenesis. Acta Neuropathol. 114 (2007) 551-571
12. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., and Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185 (2004) 232-240
13. Goodall E.F., and Morrison K.E. Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment. Expert Rev. Mol. Med. 8 (2006) 1-22
14. Gould T.W., Buss R.R., Vinsant S., Prevette D., Sun W., Knudson C.M., Milligan C.E., and Oppenheim R.W. Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J. Neurosci. 26 (2006) 8774-8786
15. Grimberg H., Levin G., Shirvan A., Cohen A., Yogev-Falach M., Reshef A., and Ziv I. Monitoring of tumor response to chemotherapy in vivo by a novel small-molecule detector of apoptosis. Apoptosis 14 (2009) 257-267
16. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264 (1994) 1772-1775
17. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
18. Ilieva E.V., Ayala V., Jove M., Dalfo E., Cacabelos D., Povedano M., Bellmunt M.J., Ferrer I., Pamplona R., and Portero-Otin M. Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 130 (2007) 3111-3123
19. Jellinger K.A. Cell death mechanisms in neurodegeneration. J. Cell. Mol. Med. 5 (2001) 1-17
20. Kassa R.M., Mariotti R., Bonaconsa M., Bertini G., and Bentivoglio M. Gene, cell, and axon changes in the familial amyotrophic lateral sclerosis mouse sensorimotor cortex. J. Neuropathol. Exp. Neurol. 68 (2009) 59-72
21. Kassiou M., Banati R., Holsinger R.M., and Meikle S. Challenges in molecular imaging of Parkinson's disease: a brief overview. Brain Res. Bull. 78 (2009) 105-108
22. Katzav A., Faust-Socher A., Kvapil F., Michaelson D.M., Blank M., Pick C.G., Shoenfeld Y., Korczyn A.D., and Chapman J. Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background. Neurobiol. Aging (2009) [Electronic publication ahead of print]
23. Loh K.P., Huang S.H., De Silva R., Tan B.K., and Zhu Y.Z. Oxidative stress: apoptosis in neuronal injury. Curr. Alzheimer Res. 3 (2006) 327-337
24. Ludemann N., Clement A., Hans V.H., Leschik J., Behl C., and Brandt R. O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS). J. Biol. Chem. 280 (2005) 31648-31658
25. Mariani E., Polidori M.C., Cherubini A., and Mecocci P. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 827 (2005) 65-75
26. Miller R.G., Mitchell J.D., Lyon M., and Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev. 1 (2007) CD001447
27. Mitsumoto H., Ulug A.M., Pullman S.L., Gooch C.L., Chan S., Tang M.X., Mao X., Hays A.P., Floyd A.G., Battista V., Montes J., Hayes S., Dashnaw S., Kaufmann P., Gordon P.H., Hirsch J., Levin B., Rowland L.P., and Shungu D.C. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 68 (2007) 1402-1410
28. Nunomura A., Moreira P.I., Lee H.G., Zhu X., Castellani R.J., Smith M.A., and Perry G. Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases. CNS Neurol. Disord. Drug Targets 6 (2007) 411-423
29. Offen D., Elkon H., and Melamed E. Apoptosis as a general cell death pathway in neurodegenerative diseases. J. Neural. Transm. Suppl. (2000) 153-166
30. Okouchi M., Ekshyyan O., Maracine M., and Aw T.Y. Neuronal apoptosis in neurodegeneration. Antioxid. Redox. Signal. 9 (2007) 1059-1096
31. Ono M., Haratake M., Saji H., and Nakayama M. Development of novel beta-amyloid probes based on 3,5-diphenyl-1,2,4-oxadiazole. Bioorg. Med. Chem. 16 (2008) 6867-6872
32. Ono M., Kawashima H., Nonaka A., Kawai T., Haratake M., Mori H., Kung M.P., Kung H.F., Saji H., and Nakayama M. Novel benzofuran derivatives for PET imaging of beta-amyloid plaques in Alzheimer's disease brains. J. Med. Chem. 49 (2006) 2725-2730
33. Palkovits M., and Brownstein M. Maps and guide to microdissection of the rat brain (1988), Elsevier
34. Parihar M.S., and Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J. Clin. Neurosci. 11 (2004) 456-467
35. Pasinelli P., Houseweart M.K., Brown Jr. R.H., and Cleveland D.W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 13901-13906
36. Pun S., Santos A.F., Saxena S., Xu L., and Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9 (2006) 408-419
37. Reshef A., Shirvan A., Grimberg H., Levin G., Cohen A., Mayk A., Kidron D., Djaldetti R., Melamed E., and Ziv I. Novel molecular imaging of cell death in experimental cerebral stroke. Brain Res. 1144 (2007) 156-164
38. Reshef A., Shirvan A., Shohami E., Grimberg H., Levin G., Cohen A., Trembovler V., and Ziv I. Targeting cell death in vivo in experimental traumatic brain injury by a novel molecular probe. J. Neurotrauma 25 (2008) 569-580
39. Reshef A., Shirvan A., Waterhouse R.N., Grimberg H., Levin G., Cohen A., Ulysse L.G., Friedman G., Antoni G., and Ziv I. Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET. J. Nucl. Med. 49 (2008) 1520-1528
40. Ribe E.M., Serrano-Saiz E., Akpan N., and Troy C.M. Mechanisms of neuronal death in disease: defining the models and the players. Biochem. J. 415 (2008) 165-182
41. Ryberg H., and Bowser R. Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev. Proteomics 5 (2008) 249-262
42. Ryu E.K., and Chen X. Development of Alzheimer's disease imaging agents for clinical studies. Front. Biosci. 13 (2008) 777-789
43. Schoser B.G., Wehling S., and Blottner D. Cell death and apoptosis-related proteins in muscle biopsies of sporadic amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve 24 (2001) 1083-1089
44. Shi Q., and Gibson G.E. Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 21 (2007) 276-291
45. Sidman R.L., Angevine J.B.J., and Pierce E.T. Atlas of the Mouse Brain and Spinal Cord (1971), Harvard Univ. Press, Cambridge
46. Tolboom N., Yaqub M., van der Flier W.M., Boellaard R., Luurtsema G., Windhorst A.D., Barkhof F., Scheltens P., Lammertsma A.A., and van Berckel B.N. Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET. J. Nucl. Med. 50 (2009) 191-197
47. Turner M.R., Kiernan M.C., Leigh P.N., and Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 8 (2009) 94-109
48. Wijesekera L.C., and Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 4 3 (2009)
49. Wood J.D., Beaujeux T.P., and Shaw P.J. Protein aggregation in motor neurone disorders. Neuropathol. Appl. Neurobiol. 29 (2003) 529-545
50. Woolley S.C., and Jonathan S.K. Cognitive and behavioral impairment in amyotrophic lateral sclerosis. Phys. Med. Rehabil. Clin. N. Am. 19 (2008) 607-617 xi
51. Yacoubian T.A., and Standaert D.G. Targets for neuroprotection in Parkinson's disease. Biochim. Biophys. Acta (2008)
52. Zang D.W., and Cheema S.S. Degeneration of corticospinal and bulbospinal systems in the superoxide dismutase 1(G93A G1H) transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci. Lett. 332 (2002) 99-102
53. Zhu X., Su B., Wang X., Smith M.A., and Perry G. Causes of oxidative stress in Alzheimer disease. Cell. Mol. Life Sci. 64 (2007) 2202-2210
54. Zilkha-Falb R., Ziv I., Nardi N., Offen D., Melamed E., and Barzilai A. Monoamine-induced apoptotic neuronal cell death. Cell Mol. Neurobiol. 17 (1997) 101-118
55. Ziv I., Melamed E., Nardi N., Luria D., Achiron A., Offen D., and Barzilai A. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons-a possible novel pathogenetic mechanism in Parkinson's disease. Neurosci. Lett. 170 (1994) 136-140